文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

甲氨蝶呤聚乙二醇酯作为药物递送系统的合成与表征

Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.

作者信息

Yousefi Gholamhossein, Foroutan Seyed Mohsen, Zarghi Afshin, Shafaati Alireza

机构信息

Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti University of Medical Sciences, 14155-6153, Iran.

出版信息

Chem Pharm Bull (Tokyo). 2010 Feb;58(2):147-53. doi: 10.1248/cpb.58.147.


DOI:10.1248/cpb.58.147
PMID:20118571
Abstract

Methotrexate (MTX) is one of the most common anticancer drugs used for chemotherapy so far. However some problems such as high toxicity and short plasma half-life, have limited its use. To overcome these limitations, conjugation with polymers such as polyethylene glycol (PEG) is one the efficient approaches which has been attempted in recent years. The aim of the present study is to synthesize esters of MTX with PEGs of different molecular weights and to characterize their physicochemical properties. Polymeric esters (MTX-PEGs) of MTX with low, medium and high molecular weight PEGs (750 D, 5000 D and 35000 D, respectively) were synthesized using dicyclohexylcarbodiimide (DCC) as coupling agent and triethylamine (TEA) as catalyst. The purification was carried out using preparative TLC. Purified esters were characterized by UV, IR and (1)H-NMR spectroscopy methods and their thermal behavior was studied by differential scanning calorimetry (DSC). Also, an isocratic HPLC method with three mobile phase systems was set to determine the partition coefficient of the esters (log P). Gel permeation chromatography (GPC) was utilized for molecular weight determination of esters, which proved 1 : 1 conjugation of drug with each polymer. The stability and solubility of esters were determined in different pH values. The spectroscopy results indicated that esteric bond between MTX and PEGs were formed. The sharp endothermic peaks for MTX-PEGs were obtained in DSC which are similar to pure polymers, whilst a wide peak was observed for MTX. The values of log P for MTX-PEGs (+4.3, obtained by HPLC method) were remarkably different from log P of MTX (-1.4, obtained by shake-flask method). The stability results showed a pH range of 3-4 and an optimum polymer mw of 5000 for maximum stability of esters. A parabolic profile obtained from solubility studies that indicated the more solubility of MTX in alkaline condition (pH>5) and MTX-PEGs in acidic conditions (pH<5). Based on our results, it is concluded that MTX-PEGs were formed on an equimolar ratio of MTX and PEGs. The higher log P observed for the esters indicated dramatic physicochemical differences between MTX and its PEG conjugates and the higher stability and solubility in acidic medium showed a promising approach to improve the drug delivery of the conjugates, specially MTX-PEG5000 in the future.

摘要

甲氨蝶呤(MTX)是目前用于化疗的最常见抗癌药物之一。然而,诸如高毒性和血浆半衰期短等问题限制了其应用。为克服这些局限性,与聚乙二醇(PEG)等聚合物共轭是近年来尝试的有效方法之一。本研究的目的是合成MTX与不同分子量PEG的酯,并表征其理化性质。以二环己基碳二亚胺(DCC)为偶联剂、三乙胺(TEA)为催化剂,合成了MTX与低、中、高分子量PEG(分别为750 D、5000 D和35000 D)的聚合物酯(MTX-PEGs)。采用制备型薄层色谱进行纯化。通过紫外光谱、红外光谱和(1)H-NMR光谱法对纯化后的酯进行表征,并通过差示扫描量热法(DSC)研究其热行为。此外,建立了一种采用三种流动相系统的等度高效液相色谱法来测定酯的分配系数(log P)。利用凝胶渗透色谱法(GPC)测定酯的分子量,结果证明药物与每种聚合物以1:1的比例共轭。在不同pH值下测定酯的稳定性和溶解度。光谱结果表明MTX与PEGs之间形成了酯键。在DSC中,MTX-PEGs出现尖锐的吸热峰,与纯聚合物相似,而MTX出现宽峰。MTX-PEGs的log P值(通过高效液相色谱法测得为+4.3)与MTX的log P值(通过摇瓶法测得为-1.4)显著不同。稳定性结果表明,酯的最大稳定性对应的pH范围为3-4,最佳聚合物分子量为5000。溶解度研究得到的抛物线表明,MTX在碱性条件下(pH>5)溶解度更高,而MTX-PEGs在酸性条件下(pH<5)溶解度更高。根据我们的结果得出结论,MTX和PEGs以等摩尔比形成了MTX-PEGs。酯的log P值较高,表明MTX与其PEG共轭物之间存在显著的理化差异,且在酸性介质中具有更高的稳定性和溶解度,这显示了一种有望改善共轭物药物递送的方法,特别是未来的MTX-PEG5000。

相似文献

[1]
Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.

Chem Pharm Bull (Tokyo). 2010-2

[2]
Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.

Bioconjug Chem. 2002

[3]
Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release.

Pharm Res. 2000-5

[4]
Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.

Pharm Dev Technol. 2018-1-18

[5]
Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.

Pharm Res. 2000-10

[6]
Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.

Drug Dev Ind Pharm. 2012-9-24

[7]
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.

Int J Pharm. 2000-8-25

[8]
Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio.

Bioconjug Chem. 2014-3-19

[9]
Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.

Drug Deliv. 2013-10-10

[10]
Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.

Colloids Surf B Biointerfaces. 2015-1-6

引用本文的文献

[1]
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.

Pharmaceuticals (Basel). 2024-2-14

[2]
β-Cyclodextrin Modified Hydrogels of Kappa-Carrageenan for Methotrexate Delivery.

Pharmaceutics. 2023-8-30

[3]
Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency.

Pharmaceutics. 2022-11-30

[4]
Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice.

Iran J Pharm Res. 2018

[5]
Toxicity, Biocompatibility, pH-Responsiveness and Methotrexate Release from PVA/Hyaluronic Acid Cryogels for Psoriasis Therapy.

Polymers (Basel). 2017-3-27

[6]
Preparation and assessment of chitosan-coated superparamagnetic Fe3O4 nanoparticles for controlled delivery of methotrexate.

Res Pharm Sci. 2013-1

[7]
Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.

Bioorg Med Chem. 2013-9-28

[8]
Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.

Int J Mol Sci. 2011

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索